<SEC-DOCUMENT>0001390478-18-000013-index.html : 20180524 <SEC-HEADER>0001390478-18-000013.hdr.sgml : 20180524 <ACCEPTANCE-DATETIME>20180524162955 ACCESSION NUMBER: 0001390478-18-000013 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20180519 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Termination of a Material Definitive Agreement ITEM INFORMATION: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20180524 DATE AS OF CHANGE: 20180524 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SELLAS Life Sciences Group, Inc. CENTRAL INDEX KEY: 0001390478 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-33958 FILM NUMBER: 18858232 BUSINESS ADDRESS: STREET 1: 315 MADISON AVENUE STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: (813) 864-4523 MAIL ADDRESS: STREET 1: 315 MADISON AVENUE STREET 2: 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 FORMER COMPANY: FORMER CONFORMED NAME: Galena Biopharma, Inc. DATE OF NAME CHANGE: 20110926 FORMER COMPANY: FORMER CONFORMED NAME: RXi Pharmaceuticals Corp DATE OF NAME CHANGE: 20110926 FORMER COMPANY: FORMER CONFORMED NAME: GALENA BIOPHARMA, INC. DATE OF NAME CHANGE: 20110922 </SEC-HEADER> <DOCUMENT> <TYPE>8-K <SEQUENCE>1 <FILENAME>sls-20180524x8xklicenseagr.htm <DESCRIPTION>8-K <TEXT> Document 1 - file: sls-20180524x8xklicenseagr.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.1 <SEQUENCE>2 <FILENAME>slsexhibit20180524-101.htm <DESCRIPTION>EXHIBIT 10.1 <TEXT> Document 2 - file: slsexhibit20180524-101.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-10.2 <SEQUENCE>3 <FILENAME>slsexhibit2018054-102.htm <DESCRIPTION>EXHIBIT 10.2 <TEXT> Document 3 - file: slsexhibit2018054-102.htm
</DOCUMENT> </SEC-DOCUMENT>